Antileishmanial agent-27
Antileishmanial agent-27 (compound 7j) is a benzothiazolo-coumarin derivative. Antileishmanial agent-27 is a competitive inhibitor of arginyl-tRNA synthetases (ArgRSs) . Antileishmanial agent-27 shows selectivity toward ArgRS of Leishmania donovani (LdArgRS) than its human counterpart (HsArgRS), with IC50 values of 1.2 and 19 μM, respectively. Antileishmanial agent-27 possesses high pharmacokinetic properties[1].
Product Specifications
CAS Number
[9007-83-4]
UNSPSC
12352005
Target
Aminoacyl-tRNA Synthetase; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antileishmanial-agent-27.html
Solubility
10 mM in DMSO
Smiles
O=C1OC2=CC(OCC3=CC=C(Br)C=C3)=CC=C2C(CSC4=NC5=C(S4)C=CC=C5)=C1
Molecular Formula
C24H16BrNO3S2
Molecular Weight
510.42
References & Citations
[1]Nasim F, et al. Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl-tRNA synthetase. FEBS J. 2024 Mar 25.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Explore Other Products
Browse additional items from our catalog
SLC9A8 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
![Mouse Hoxb13 Antibody (Center) [APR04075G]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
![Mouse Hoxb13 Antibody (Center) [APR04075G]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)